Hemab Therapeutics Holdings, Inc. (COAG)

NASDAQ: COAG · Real-Time Price · USD

25.34

-8.66 (-25.47%)

At close: May 4, 2026, 4:00 PM EDT

25.00

-0.34 (-1.34%)

After-hours: May 4, 2026, 7:28 PM EDT

COAG Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	May '26 May 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Market Capitalization	1,120	-	-
Enterprise Value	936	-	-
Debt / Equity Ratio	0.01	0.01	0.02
Net Debt / Equity Ratio	-1.00	-1.00	-0.98
Net Debt / EBITDA Ratio	2.64	2.64	1.73
Net Debt / FCF Ratio	3.00	3.00	1.89
Quick Ratio	17.62	17.62	13.45
Current Ratio	18.03	18.03	13.95
Return on Equity (ROE)	-46.99%	-46.99%	-
Return on Assets (ROA)	-30.11%	-30.11%	-
Return on Capital Employed (ROCE)	-38.10%	-38.10%	-56.20%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q